With AI use on the rise, clinical development is also not far behind in using AI technology. AI is actively changing how ...

Pheiron and Ribo are excited to announce that the first two strategic collaboration milestones have been successfully ...

Effective drug discovery and development hinge on high-quality data. Implementing FAIR principles enhances data usability and ...

Phase I trial results show the potential of once-yearly lenacapavir as a long-acting PrEP option for HIV, supporting further ...

Elucid, an AI medical technology company focused on providing physicians with a more precise view of atherosclerosis to drive ...

Vivace Therapeutics has closed $35m in a Series D financing round to support the clinical development of its cancer drug ...

High antibody titers of anti–citrullinated peptide antibodies, rheumatoid factor, and certain baseline factors predict RA ...

Genmab has stopped clinical development of a blood cancer treatment after Johnson & Johnson decided it won't exercise its option to license it.

For more information on the Phase 1b clinical trial, visit: https://clinicaltrials.gov/study/NCT06732180 ...